FAB CBD Pioneers the Global Cannabinoid Industry
Though still a burgeoning industry, cannabinoids have been continually growing in popularity among consumers throughout the United States and the global economy across the past decade. Thanks to recent cannabis legalization efforts in the United State, an issue expected to come to a head in the U.S. House of Representatives this March as the legislative body is slated to debate on cannabis’ federal legalization, the newly-approved legal marijuana market has been booming, with more and more Americans electing to participate as consumers in this fast-growing industry. Now, the global community is catching onto the CBD trend in turn, with the international cannabinoid market anticipated to grow at a quick compound annual growth rate of 21.2 percent from 2021 to 2028. But alongside the mass acceptance and popularization of marijuana on a worldwide scale has arrived another intriguing, lesser-known sector of the industry: cannabidiols, commonly known as CBD.
One of the 113 cannabinoids found within the marijuana plant, CBD has been gaining repute across the world for its potential role in the medical world and as a staple in at-home medicine cabinets. With clinical research demonstrating the cannabinoids’ propensity to provide many solutions for consumers, CBD has begun to build its own unique user base of consumers that want to benefit from all of the positive properties of the cannabis plant, without having to get high in the process.
As the global CBD industry hurdles toward an impressive $29.91 billion valuation by 2025, a few key players are leading the way to cannabinoids’ continual acceptance, including FAB CBD. Offering a variety of more than 40 products that cater to any lifestyle, including oils, gummies, creams, and salves, FAB has left no stone unturned in its quest to make quality CBD attainable for all – including CBD Oil, Daytime and Nighttime Gummies, Topicals as well as Dog Treats. All of FAB CBD’s products have been third-party tested and some are even award-winning!
“All of our formulations at FAB CBD are driven by science, innovation, and attention to customer needs,” said Founder Josh Delaney. “We do our homework and put time and care into every supplement we create, from the sourcing of ingredients to the manufacture of the products and the customer experience of purchasing and using what they buy from us. We put enormous effort into making sure there is no weak link in the process, ensuring only the best outcomes for our customers.”
Quickly rising to the top of the CBD marketplace since its foundation in 2017, FAB CBD has been bolstered in its success due to the team’s unrivaled marketing expertise, who used their extensive network and advertising prowess to make the powers of CBD accessible to the home consumer. The team behind FAB has a background in the wellness supplements market, which contributed to the quick expansion of FAB CBD, as the founder’s pre-established knowledge of the development and manufacturing process of health products at the company played a significant role in the Fab CBD’s continued upward trajectory. They pride themselves on being an education-based company, providing blogs and content to help customers understand what they are using and why.
With publicly-traded cannabis powerhouse High Tide Inc. now at the helm of FAB CBD, the burgeoning CBD brand is quickly growing into one of the United States’ leading cannabinoid companies and consistently pulls in millions of dollars in EBITDA annually, and is picking up speed in gaining recognition across the international marketplace. And with a third of surveyed Americans counting CBD products as a part of their routines as of 2020, FAB CBD’s grip on the growing cannabinoid market seems here to stay as the use of CBD becomes increasingly commonplace around the world.